ENZO BIOCHEM INC. COMMON STOCK ($0.01 PAR VALUE)

Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update

15 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

Enzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15th

02 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER

09 Nov 2021 10:18:09 By Nasdaq GlobeNewswire

Enzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexually Transmitted Infections

21 Oct 2021 08:38:53 By Nasdaq GlobeNewswire

HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS

18 Oct 2021 08:17:12 By Nasdaq GlobeNewswire

Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update

12 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th

28 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

ENZO BIOCHEM TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE

02 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2

20 Jul 2021 08:00:01 By Nasdaq GlobeNewswire

Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel

15 Jun 2021 12:00:00 By Nasdaq GlobeNewswire

Enzo Biochem Reports Third Quarter Fiscal 2021 Results

09 Jun 2021 16:05:00 By Nasdaq GlobeNewswire

Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9

01 Jun 2021 16:05:00 By Nasdaq GlobeNewswire

Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization

21 Apr 2021 08:00:00 By Nasdaq GlobeNewswire

ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM

17 Mar 2021 16:15:00 By Nasdaq GlobeNewswire

Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates

15 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference

04 Mar 2021 08:00:04 By Nasdaq GlobeNewswire

Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15

01 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin

03 Feb 2021 08:29:57 By Nasdaq GlobeNewswire

ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES

20 Jan 2021 08:13:46 By Nasdaq GlobeNewswire

ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT

05 Jan 2021 08:00:02 By Nasdaq GlobeNewswire